Division of Endocrine and Oncological Surgery, Department of Surgery, Tulane University Medical Center, New Orleans, Louisiana, USA.
Head Neck. 2011 Apr;33(4):543-6. doi: 10.1002/hed.21482. Epub 2010 Sep 24.
Minimally invasive parathyroidectomy has become increasingly popular for the treatment of primary hyperparathyroidism, but is not a feasible option for multiglandular disease. It has been suggested that preoperative intact parathyroid hormone (iPTH) levels may predict multiglandular disease. We examined this hypothesis in patients who underwent surgical intervention for primary hyperparathyroidism at Johns Hopkins Medical Institutions.
We retrospectively reviewed 502 consecutive patients with primary hyperparathyroidism who underwent parathyroidectomy. Multivariable logistic regression analysis assessed preoperative iPTH levels as a predictor of multiglandular disease and a positive sestamibi scan, after adjustment for age, sex, and race.
Preoperative iPTH levels were not significantly associated with a greater likelihood of multiglandular disease. However, sestamibi scan positivity was significantly more likely in patients with higher preoperative iPTH levels.
Preoperative iPTH levels are not helpful in predicting multiglandular disease and should not be used to exclude a minimally invasive parathyroidecotomy for patients with primary hyperparathyroidism. © 2010 Wiley Periodicals, Inc. Head Neck, 2011.
微创甲状旁腺切除术已成为治疗原发性甲状旁腺功能亢进症的一种日益流行的方法,但对于多腺体疾病并非可行的选择。有人提出术前完整甲状旁腺激素(iPTH)水平可能预测多腺体疾病。我们在约翰霍普金斯医疗机构接受手术干预的原发性甲状旁腺功能亢进症患者中检验了这一假说。
我们回顾性分析了 502 例连续的原发性甲状旁腺功能亢进症患者,这些患者均接受了甲状旁腺切除术。多变量逻辑回归分析评估了术前 iPTH 水平作为多腺体疾病和阳性 sestamibi 扫描的预测因子,调整了年龄、性别和种族因素。
术前 iPTH 水平与多腺体疾病的可能性增加无显著相关性。然而,术前 iPTH 水平较高的患者 sestamibi 扫描阳性的可能性更大。
术前 iPTH 水平无助于预测多腺体疾病,不应将其用于排除原发性甲状旁腺功能亢进症患者的微创甲状旁腺切除术。©2010 Wiley Periodicals, Inc. Head Neck, 2011.